✦ LIBER ✦

Mitoxantrone and ifosfamide as second-line therapy of epithelial ovarian cancer. a pilot study by the I.T.M.O. group

✍ Scribed by Di Leo, A.; Bajetta, E.; Bohm, S.; Lupi, G.; Biganzoli, L.; Oriana, S.; Riboldi, G.; Spatti, G.; Zunino, F.; Di Re, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of G-CSF activity given by in

✍ Di Leo, A.; Bajetta, E.; Nolè, F.; Raspagliesi, F.; Riboldi, G.; Spatti, G.B.; B 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 171 KB

An I.T.M.O. group study on second-line t

✍ A. Di Leo; E. Bajetta; L. Biganzoli; S. Bohm; L. Mariani; S. Mènard; S. Pilotti; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 860 KB

Feasibility of cisplatin (DDP) + topotec

✍ N. Iedà; A. Lissoni; G. Zanetta; G. Caspani; F. Fei; G. Brancatelli; E. Marinett 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Improving first-line therapy of advanced

✍ A. Du Bois; J. Pfisterer; W. Meier; U. Wagner; for the ago Ovarian Cancer Study 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

533 - Independent radiological review of

✍ S.J. Gwyther; M. Gore; W. ten Bokkel Huinink; S.Z. Fields; I. Hudson 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 378 KB

6626 POSTER Efficacy and Safety of RAD00

✍ Buzzoni, R.; Pusceddu, S.; Biondani, P.; Cantore, M.; Aitini, E.; Bertolini, A.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB